✦ LIBER ✦

De Novo Immunosuppression With Mammalian Target of Rapamycin Inhibitors and Posttransplantation Malignancy in Focus

✍ Scribed by S. Flechner; P. Friend; J. Campistol; M. Weir; F. Diekmann; G. Russ

Book ID: 116935494
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 100 KB
Volume: 41
Category: Article
ISSN: 0041-1345
DOI: 10.1016/j.transproceed.2009.06.158

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Rescue Immunosuppression With Mammalian

Rescue Immunosuppression With Mammalian Target of Rapamycin Inhibitor Drugs in Liver Transplantation

✍ J.M.A. Mártinez; L.B. Pulido; C.B. Bellido; D.D. Usero; L.T. Aguilar; J.L.G. Mor 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 97 KB

The role of mammalian target of rapamyci

The role of mammalian target of rapamycin inhibitors in the management of post-transplant malignancy

✍ Klintmalm, Goran B.; Saab, Sammy; Hong, Johnny C.; Nashan, Björn 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 177 KB

Efficacy, Tolerance, and Safety of Mamma

Efficacy, Tolerance, and Safety of Mammalian Target of Rapamycin Inhibitors as Rescue Immunosuppressants in Liver Transplantation

✍ J.M. Alamo; L. Barrera; M.D. Casado; C. Bernal; L.M. Marin; G. Suarez; L. Sanche 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 97 KB

Intestinal Kaposi sarcoma in a lung tran

Intestinal Kaposi sarcoma in a lung transplant recipient: Therapy with mammalian target of rapamycin inhibitor and immunosuppression reduction

✍ Lund, May Brit; Paulsen, Vemund; Aukrust, Pål 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 62 KB

Mammalian target of rapamycin inhibitors

Mammalian target of rapamycin inhibitors and their potential role in therapy in leukaemia and other haematological malignancies

✍ David T. Teachey; Stephan A. Grupp; Valerie I. Brown 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 194 KB

Preliminary characterization of oral les

Preliminary characterization of oral lesions associated with inhibitors of mammalian target of rapamycin in cancer patients

✍ Stephen Sonis; Nathaniel Treister; Sant Chawla; George Demetri; Frank Haluska 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 176 KB

## Abstract ## BACKGROUND: Mammalian target of rapamycin (mTOR) inhibitors may have efficacy as an intervention for advanced malignancies. Oral ulceration (OU), reported as mucositis, has been a dose‐limiting toxicity for this new class of agents. An analysis of the appearance, course, and toxicit